These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 9870424)

  • 1. The effect of metabolic control on development and progression of diabetic nephropathy.
    Di Landro D; Catalano C; Lambertini D; Bordin V; Fabbian F; Naso A; Romagnoli GF
    Nephrol Dial Transplant; 1998; 13 Suppl 8():35-43. PubMed ID: 9870424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic nephropathy and end-stage renal failure: the Norwegian story.
    Bergrem H; Leivestad T
    Adv Ren Replace Ther; 2001 Jan; 8(1):4-12. PubMed ID: 11172323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dynamics of diabetic nephropathy and other complications of type I diabetes mellitus in the period of 1996-2002 (data from 2 Kaunas outpatient polyclinics)].
    Bumblyte IA; Pakalnyte R; Radzeviciene L; Sepetauskiene E; Gaupsiene E; Kavaliauskiene J
    Medicina (Kaunas); 2003; 39 Suppl 1():51-8. PubMed ID: 12761421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression of renal failure in diabetic nephropathy.
    Marcantoni C; Ortalda V; Lupo A; Maschio G
    Nephrol Dial Transplant; 1998; 13 Suppl 8():16-9. PubMed ID: 9870420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The risk for diabetic nephropathy is low in young adults in a 17-year follow-up from the Diabetes Incidence Study in Sweden (DISS). Older age and higher BMI at diabetes onset can be important risk factors.
    Svensson MK; Tyrberg M; Nyström L; Arnqvist HJ; Bolinder J; Östman J; Gudbjörnsdottir S; Landin-Olsson M; Eriksson JW
    Diabetes Metab Res Rev; 2015 Feb; 31(2):138-46. PubMed ID: 25044633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic nephropathy: from micro- to macroalbuminuria.
    Deferrari G; Repetto M; Calvi C; Ciabattoni M; Rossi C; Robaudo C
    Nephrol Dial Transplant; 1998; 13 Suppl 8():11-5. PubMed ID: 9870419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care.
    Agardh CD; Agardh E; Torffvit O
    Diabetes Res Clin Pract; 1997 Mar; 35(2-3):113-21. PubMed ID: 9179466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concerns about diabetic nephropathy in the treatment of diabetic hypertensive patients.
    Tolins JP; Raij L
    Am J Med; 1989 Dec; 87(6A):29S-33S. PubMed ID: 2688411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Losartan and other angiotensin II antagonists for nephropathy in type 2 diabetes mellitus: a review of the clinical trial evidence.
    Ruilope LM; Segura J
    Clin Ther; 2003 Dec; 25(12):3044-64. PubMed ID: 14749145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nephropathy of type II diabetes mellitus.
    Ritz E; Keller C; Bergis KH
    Nephrol Dial Transplant; 1996; 11 Suppl 9():38-44. PubMed ID: 9050034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of metabolic control on rate of decline in renal function in insulin-dependent diabetes mellitus with overt diabetic nephropathy.
    Mulec H; Blohmé G; Grände B; Björck S
    Nephrol Dial Transplant; 1998 Mar; 13(3):651-5. PubMed ID: 9550642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retarding the progression of diabetic nephropathy in type 2 diabetes mellitus: focus on hypertension and proteinuria.
    Lee GS
    Ann Acad Med Singap; 2005 Jan; 34(1):24-30. PubMed ID: 15726216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships among microalbuminuria, insulin resistance and renal-cardiac complications in insulin dependent and non insulin dependent diabetes.
    Nosadini R; Brocco E
    Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():1-7. PubMed ID: 9288531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention and slowing down the progression of the diabetic nephropathy through antihypertensive therapy.
    Bretzel RG
    J Diabetes Complications; 1997; 11(2):112-22. PubMed ID: 9101397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cigarette smoking is a risk factor for nephropathy and its progression in type 2 diabetes mellitus.
    Gambaro G; Bax G; Fusaro M; Normanno M; Manani SM; Zanella M; Dangelo A; Fedele D; Favaro S
    Diabetes Nutr Metab; 2001 Dec; 14(6):337-42. PubMed ID: 11853366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High incidence of diabetic nephropathy in early-onset Japanese NIDDM patients. Risk analysis.
    Yokoyama H; Okudaira M; Otani T; Watanabe C; Takaike H; Miuira J; Yamada H; Mutou K; Satou A; Uchigata Y; Iwamoto Y
    Diabetes Care; 1998 Jul; 21(7):1080-5. PubMed ID: 9653599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Risk and prevention of diabetic nephropathy].
    Ravera M; Re M; Deferrari G
    G Ital Nefrol; 2007; 24 Suppl 38():13-9. PubMed ID: 17922442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of microalbuminuria in patients with type 2 diabetes mellitus.
    Jerums G; MacIsaac RJ
    Treat Endocrinol; 2002; 1(3):163-73. PubMed ID: 15799209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between glucose control and the development of diabetic nephropathy in type I diabetes.
    Molitch ME
    Semin Nephrol; 1997 Mar; 17(2):101-13. PubMed ID: 9148376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Urinary albumin excretion by patients with type 2 diabetes mellitus. Effect of blood pressure and metabolic regulation].
    Jungmann E; Carlberg C; Schallmayer M; Schumm-Draeger PM
    Med Klin (Munich); 1995 Jul; 90(7):383-9. PubMed ID: 7675002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.